Drug Shortage Report for NAPROSYN

Last updated on 2024-05-14 History
Report ID 204887
Drug Identification Number 02162423
Brand name NAPROSYN
Common or Proper name Naproxen sodium tablets USP
Company Name ATNAHS PHARMA UK LIMITED
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL ORAL
Packaging size 100s
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-09-21
Estimated end date 2024-07-15
Actual end date
Shortage status Actual shortage
Updated date 2024-05-14
Company comments Manufacturing delays
Health Canada comments
Tier 3 Status No
Contact Address SOVEREIGN HOUSE, MILES GRAY ROAD
BASILDON, ESSEX
GREAT BRITAIN SS14 3FR
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2023-09-21 English Compare
v2 2023-09-21 French Compare
v3 2023-09-21 English Compare
v4 2023-09-21 English Compare
v5 2023-09-21 French Compare
v6 2023-09-22 English Compare
v7 2023-11-13 English Compare
v8 2023-11-13 French Compare
v9 2023-11-24 English Compare
v10 2023-11-24 French Compare
v11 2024-03-01 English Compare
v12 2024-03-01 French Compare
v13 2024-05-14 English Compare

Showing 1 to 13 of 13